Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
KYNB

Kyntra Bio, Inc. (KYNB)

NASDAQ
$2.05
-$1.13
(-35.31%)
After-Hours

Last updated: ⁦2026-11-17 21:49:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Kyntra Bio, Inc. (KYNB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.05, with a market capitalization of $13.93M and a P/E ratio of 0.07. Over the past 52 weeks, its price has ranged from $2.00 to $9.70. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$13.93M

$2.33

$3.03

$2.00

$3.20

236.30K

25.40K

0.07

$9.70

$2.00

--

--

Kyntra Bio, Inc. (KYNB) After-Hours Stock Price

Kyntra Bio, Inc. (KYNB) is trading at $2.19 in after-hours trading as of 2026-11-17 21:38:00, up 7.09% ($0.15) from the regular-session close of $2.05.

After-hours trading shows how investors are pricing KYNB after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

Why Is KYNB Stock Up Today?

KYNB is up 3.30% in after-hours trading.

Kyntra Bio shares are trading lower after the company reported mixed Q3 financial results. Also, HC Wainwright & Co. lowered its price target on the stock from $43 to $18.

Source: Benzinga · Updated

Kyntra Bio, Inc. (KYNB) 7-Day Stock Price Change

Over the past seven days, Kyntra Bio, Inc. (KYNB) moved from $3.73 to $2.05, representing a decline of 45.17% ($1.69).

The stock traded between $2.00 and $4.10 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 32.29 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

KYNB 52-Week Price Position

Position in Range: 0.6%

52W Low$2.00
52W High$9.70

KYNB is currently trading at $2.05, placing it 0.6% of the way from its 52-week low of $2.00 to its 52-week high of $9.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Kyntra Bio, Inc. (KYNB)?

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Kyntra Bio, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
34
Exchange
NASDAQ
Company Website

KYNB News

Latest news related to Kyntra Bio, Inc. and KYNB stock.

  • Benzinga

    Lake Street Maintains Buy on Kyntra Bio, Lowers Price Target to $8

    Lake Street analyst Daniel Brims maintains Kyntra Bio (NASDAQ:KYNB) with a Buy and lowers the price target from $41 to $8.

    Read Full Article
  • Benzinga

    12 Health Care Stocks Moving In Tuesday's Intraday Session

    Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q3 earnings

    Read Full Article
  • Benzinga

    Oppenheimer Maintains Outperform on Kyntra Bio, Lowers Price Target to $30

    Oppenheimer analyst Jay Olson maintains Kyntra Bio (NASDAQ:KYNB) with a Outperform and lowers the price target from $35 to $30.

    Read Full Article
  • Benzinga

    HC Wainwright & Co. Maintains Buy on Kyntra Bio, Lowers Price Target to $18

    HC Wainwright & Co. analyst Matthew Keller maintains Kyntra Bio (NASDAQ:KYNB) with a Buy and lowers the price target from $43 to $18.

    Read Full Article
  • Benzinga

    Update: Kyntra Bio Q3 Adj. EPS $(3.42) Beats $(3.55) Estimate, Sales $1.762M Miss $1.766M Estimate

    Kyntra Bio (NASDAQ:KYNB) reported quarterly losses of $(3.42) per share which beat the analyst consensus estimate of $(3.55) by 3.66 percent. This is a 5.23 percent decrease over losses of $(3.25) per share from the

    Read Full Article

Ways to Trade KYNB at MEXC

KYNB MEXC RealStocks

Own real KYNB shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Kyntra Bio, Inc. (KYNB) Stock on MEXC

Eligible investors can buy real shares of Kyntra Bio, Inc. (KYNB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for KYNB and Place Your Order
Step 3: Search for KYNB and Place Your Order
Open the RealStocks trading page and search for KYNB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Kyntra Bio, Inc. (KYNB) stock price today?
Kyntra Bio, Inc. (KYNB) is currently trading at $2.05, down 35.31% ($1.13) from the previous close of $3.20. Intraday prices update in real time during regular trading hours.
2.Is KYNB stock going up or down today?
As of 2026-11-17 21:38:00, KYNB is trading at $2.05, down 35.31% ($1.13) from its previous close of $3.20. The stock has traded between $2.00 and $3.03 during today’s regular session. Past price movements do not guarantee future results.
3.What is KYNB pre-market price?
As of 2026-11-17 21:38:00, KYNB is trading at $2.44 in pre-market trading, down 23.72% ($0.76) from the previous close of $3.20. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is KYNB after-hours price?
As of 2026-11-17 21:38:00, KYNB is trading at $2.19 in after-hours trading, up 7.09% ($0.15) from the regular-session close of $2.05. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is KYNB stock trading now?
KYNB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does KYNB sit relative to its 52-week high and low?
Over the past 52 weeks, KYNB has traded between a low of $2.00 and a high of $9.70. At $2.05, the stock is positioned 0.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Kyntra Bio, Inc. in?
Kyntra Bio, Inc. (KYNB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Kyntra Bio, Inc.'s market capitalization and where is it listed?
Kyntra Bio, Inc. is listed on the NASDAQ exchange with a market capitalization of $13.93M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is KYNB valued in terms of P/E ratio and EPS?
KYNB trades at a P/E ratio of 0.07, based on trailing-twelve-month EPS of $45.24. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Kyntra Bio, Inc. pay a dividend?
Kyntra Bio, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to KYNB, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

KYNB Stock Calculator

Estimate the value between KYNB shares and USD.

KYNB Shares to USD

KYNB Shares
KYNB
KYNB
USD
USD
USD

1.00 KYNB shares = 2.045 USD

Calculations are estimates based on the latest available price and are for reference only.